Distinctive molecular features of radiation-induced thyroid cancers.

Karyadi, Danielle M; Bogdanova, Tetiana I; Milder, Cato M; Hartley, Stephen W; Lee, Olivia W; Dean, Michael; Drozdovitch, Vladimir; Cahoon, Elizabeth K et al. · Sci Adv · 2025

basic_science · Level V

Where this comes from

Abstract

Papillary thyroid carcinoma (PTC) incidence increased after childhood exposure to radioactive fallout from the Chornobyl accident. We investigated PTC genomic profiles to distinguish radiation-induced versus sporadic oncogenic drivers by modeling dose and molecular characteristics by driver category: <i>BRAF<sup>V600E</sup></i> (<i>n</i> = 132), RAS mutation (<i>n</i> = 31), fusions generated from two breakpoints and <20 base pairs (bp) breakpoint gain/loss (Fusion<sup>2B<20bp</sup>; <i>n</i> = 63), or ≥3 breakpoints and ≥1000 bp breakpoint loss (<i>n</i> = 20). The frequency of Fusion<sup>2B<20bp</sup>-PTC increased with increasing thyroid radiation dose, whereas all others declined. Clonal small deletion counts increased with increasing radiation dose for Fusion<sup>2B<20bp</sup>-PTC (<i>P</i> = 5.1 × 10<sup>-4</sup>) but not other drivers (<i>P</i> > 0.08). Clonal clock mutational signatures, marking the age of tumor initiation, were associated with age at the accident for Fusion<sup>2B<20bp</sup>-PTC (<i>P</i> = 8.2 × 10<sup>-4</sup>) but not other drivers (<i>P</i> > 0.21). Together, these results support a causal role for ionizing radiation in Fusion<sup>2B<20bp</sup>-PTC as a group but not other drivers.

Medical subject headings